Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 35
Judge Finds Plaintiff's Claims Not 'Truly' Severed, Remands Case
MDL Judge Rejects Plaintiffs' Pursuit of 2nd-Filed, State Vioxx Actions
Plaintiffs Seek Appeal of Court's Protective Order for Martin Report
N.J. Jury Awards $47.5 Million to Idaho Couple in Vioxx Trial
Learned Intermediary Bars Humira Neurological Disorder Claim, Judge Says
Merck to Appeal $7.75M Verdict After Judge's Inaction Let Award Stand
Arthritis Drugs - Issue: 34
Vioxx MDL Court to Hear Oral Argument on Motions for New Trials
FDA Advisory Panel to Review Safety of Merck's Cox-2 Arcoxia
